Page 152 - GPD-4-1
P. 152

Gene & Protein in Disease                                         FXR1 modulates gene expression in cancer



            were validated through conventional PCR (Figure 1B) and   RNA was isolated, and qRT-PCR assays were performed to
            qRT-PCR (Figure 1C), providing compelling evidence that   quantify the expression levels of the selected genes under
            FXR1 binds to a diverse range of mRNAs and suggesting   conditions of FXR1 depletion and overexpression. The data
            its significant role in gene expression regulation. p21 was   indicated significant alterations in the expression of these
            used as a positive control based on a previous study,  and   selected genes when FXR1 expression was either knocked
                                                      12
            β-actin served as a negative control. Further investigations   down or enhanced (Figures 3 and 4). Specifically, silencing
            are necessary to explore the functional consequences of   FXR1 resulted in a marked reduction in the expression
            these interactions and to identify additional FXR1 targets   of  several genes,  including  SLC43A3,  ACKR3,  KCNN3,
            that may have been overlooked in this study.       LEMD1, GPR35,  WNT7A, F2RL3,  and  ANO5 (Figure  3).
                                                               Conversely, overexpression of FXR1 led to decreased
            3.2. FXR1 modulates the expression of the key      mRNA levels of other genes, such as  SHISAL1,  NBAT1,
            selected genes                                     PDZK1IP1, NECAB2, ATOH8, and IGFBP7 (Figure 4). This

            Next, we overexpressed FXR1 and conducted stable   dual modulation highlights the critical role of FXR1 in both
            knockdown experiments to explore the potential regulatory   upregulating and downregulating key genes involved in
            relationship between FXR1 and the expression of target   cellular processes. These findings suggest that FXR1 acts as a
            genes (Figure  2). The origninal (uncropped) WB images   central regulator of gene expression, influencing the balance
            are provided in supplementary Figures R1 and R2. Total   between oncogenic and tumor-suppressive pathways.

                         A                           B























                         C
















            Figure 1. RNA immunoprecipitation (RIP) analysis. (A) A schematic representation illustrates the workflow of the RNA-IP assay, highlighting the use
            of an FXR1 antibody to isolate RNA-protein complexes. (B) Total RNA was extracted from RNA-IP samples, followed by PCR to assess the enrichment
            of specific mRNAs within the immunoprecipitated complex.  (C) Total RNA was extracted from RNA-IP samples, followed by qRT-PCR to assess the
            enrichment of specific mRNAs within the immunoprecipitated complex.
            Abbreviations: Ab: Antibody; IgG: Immunoglobin G; M: Marker; PCR: Polymerase chain reaction; qRT-PCR: Quantitative reverse transcription-
            polymerase chain reaction.



            Volume 4 Issue 1 (2025)                         6                               doi: 10.36922/gpd.5068
   147   148   149   150   151   152   153   154   155   156   157